And the beat goes onis a refrain that kept rolling through my head after attending the symposium Tuesday hosted by the Womens Institute for a Secure Retirement (WISER) in Washington, D.C. The topic: retirement solutions for women.
Our Top Pick for conservative investors for the coming year is a company that went through a management overhaul in 2015, leaving investors uncertain about the company’s future, observes Crista Huff, editor of Cabot Undervalued Stocks Advisor.
Mattel (MAT) markets toys globally under the brand names Mattel, Fisher-Price, RoseArt, Barbie, AmericanGirl and many more, including strategic....More>>>
Sports fans know that building a championship sports roster requires a successful mix of many factors: great scouting, superior management, and, arguably the most important factor of all – money. Star players often command higher salary, meaning teams must be willing to sign multi-million dollar contracts to secure the best talent to put their team in a position to win....More>>>
Trump just past the final stage to become the U.S. President, and the Electoral College confirmed that Donald J. Trump will be the 45th President of the U.S. Like it or not, Trump is taking office and could affect the markets. After Trump won the election, markets have been trending higher and making all-time highs. As seen on the SPDR S&P 500 ETF Chart below:
Nu Skin Enterprises Inc (NYSE:NUS) has been on my radar for quite some time now, simply because of its association with the infamous Herballife (NYSE:HLF) (which I will write about in part-2 of this series). I will not discuss in either of these articles the moral attributes of these companies as multi-level marketing, but solely as an investment opportunity to profit with....More>>>
With trading slowing down as another holiday weekend approaches, there just weren’t enough sellers today to muster a meaningful follow through on Wednesday’s weakness. The S&P 500‘s close of 2,249.26 was a mere 0.03% weaker than yesterday’s last trade.
Not every name escaped Thursday’s action unscathed though. Cempra Inc (NASDAQ:CEMP), Groupon Inc (NASDAQ:GRPN)....More>>>
In 2016, the U.S. solar energy market installed 14,762 megawatts, up from 7,501 megawatts installed in 2015. More new solar generation capacity came online in 2016 than capacity from any other fuel source.
Growth in installation of residential solar slowed down year over year from record growth in 2015. The decline was attributed to lower installations in the second half of the year in several....More>>>
Related MPEL 10 Notable Stocks Trading Ex-Dividend Friday, November 11 What Does The Mixed Bag Of Gaming Results Thus Far Predict For MGM? Related WYNN New York Welcomes UFC With Open Arms: What Does That Mean For Las Vegas? 10 Notable Stocks Trading Ex-Dividend Tuesday, November 15 The Vetr community has....More>>>
Last week, Energy Transfer Partners (NYSE:ETP) finally resumed work on the controversial Dakota Access Pipeline after it received a green signal from the Army Corps of Engineers. The MLP expects to complete its $4.8 billion Bakken Pipeline project, which includes the 1,172-mile DAPL and the 754-mile ETCO pipeline, in 2Q2017. Moreover, the approval is also a sign of positive things to come for....More>>>
“A truly great business must have an enduring “moat” that protects excellent returns on invested capital.”
– Warren Buffett, 2007 Shareholder Letter
A reader recently sent me the following clips from the 2007 Shareholder Letter that pertains to a topic that we’ve discussed quite a bit here: the concept of return on capital, why it’s important....More>>>
Heres a roundup of everything we covered on Barrons Stocks to Watch today:
Andy Newman/Associated Press
It was a big day for specialty pharmaceutical companies. We dug into Valeant Pharmaceutical International’s (VRX) 25% surge following its guidance and thebeginning of its asset sales, and Endo International’s (ENDP) 22% rise following its own earnings.
On Friday, small cap biotechArrowhead Pharmaceuticals (NASDAQ: ARWR) jumped 18.28% after hosting an investor & analyst R&D day to introduce its proprietary Targeted RNAi Molecule (TRiMTM) platform and to review its pipeline of RNAi therapeutic candidates. Arrowhead Pharmaceuticals develop